Dedicated funds are available for a one-year grant through The Charlie Landers Foundation to support Pediatric Ewing Sarcoma research. This award includes the potential for a second year of funding based on demonstrated progress and the joint approval of the Boards of Directors of The Charlie Landers Foundation.
Grants range from $20,000-$150,000 with the potential for a second year of funding based on demonstrated progress and joint approval.
Both new and established researchers with their MD, PhD, or dual MD PhD are invited to apply for a CL7 research grant.
"In order to get people to come up with a cure for Ewing’s Sarcoma, you need people studying Ewing’s sarcoma, focus on the young investigators."
Dr. Michael Kinnaman
Memorial Sloan Kettering Cancer Center
Innovative and transformative pre-clinical, translational, and clinical research, that has the potential to immediately impact the lives of Ewing's sarcoma patients. CL7 Grants awarded in 2023 totaling $350,014. Below are the studies that we funded in our previous grant cycle.
“The role of galectin- 3 in metastatic Ewing Sarcoma” conducted by Dr. Kelly M. Bailey.
"Targeting DNA replication stress in Ewing sarcoma tumors" conducted by Dr. David Gordon.
“Clinical Translation of circulating tumor DNA (ctDNA) liquid biopsies for patients with Ewing sarcoma” conducted by Dr. David Shulman.
"Dissecting and targeting PAK4-mediated signaling in Ewing sarcoma development and metastasis” conducted by Dr. Jason T. Yustein
Please check back for our Fall Grant Announcement, Proposal Details and Budget Template in October, 2023. Together, let’s strike out Ewing’s Sarcoma!
October 2023 Publish RFP
January 2024 Grant Application Deadline
February 2024 Medical Advisory Board Review of Applications
March 2024 Medical Advisory Board/CL7 Grant Committee Meeting
March 2024 Announcement of Recipient post Decision
July 2024 Start of Grant
The Charlie Landers Foundation supports innovative and transformative pre-clinical, translational, and clinical research that has the potential to immediately impact the lives of Ewing’s sarcoma patients.
Your research could help save lives. Inquire about our grants today and see how you can make a difference.